Biomarker Clinical Phase Outsourcing Services Global Market Report 2024

Global Biomarker Clinical Phase Outsourcing Services Market Report 2024

Biomarker Clinical Phase Outsourcing Services Global Market Report 2024 – By Type (Surrogate Endpoints, Predictive Biomarker, Prognostic Biomarker, Safety Biomarker, Other Biomarker Types), By Service Type (Biomarker Validation, Biomarker Testing Services, Biomarker Sample Analysis), By Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases, Other Therapeutic Areas), By End-User (Pharmaceutical Companies, Biotechnology Companies, Academic And Research Institutions) – Market Size, Trends, And Global Forecast 2024-2033

Name: Biomarker Clinical Phase Outsourcing Services Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Biomarker Clinical Phase Outsourcing Services Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Biomarker Clinical Phase Outsourcing Services Global Market Report 2024

Proud Members Of

Biomarker Clinical Phase Outsourcing Services Market Definition

Biomarker clinical phase outsourcing services refer to the practice of contracting specialized firms or organizations to conduct various aspects of clinical trials related to biomarkers. Biomarkers are measurable indicators of biological states or conditions, often used in medical research and clinical trials to assess the effectiveness or safety of a drug or treatment.

The main types of biomarker clinical phase outsourcing services are surrogate endpoints, predictive biomarkers, prognostic biomarkers, safety biomarkers, and others. Surrogate endpoints are biomarkers intended to substitute for a clinical endpoint and Outsourcing services utilize surrogate endpoints to streamline clinical trials by providing early indications of efficacy, reducing trial duration, and potentially accelerating regulatory approvals. Service types such as biomarker validation, biomarker testing services, and biomarker sample analysis are used for therapeutic areas that include oncology, neurology, cardiology, autoimmune diseases, and others. The end users are pharmaceutical companies, biotechnology companies, and academic and research institutions.

Biomarker Clinical Phase Outsourcing Services Market Segmentation

The biomarker clinical phase outsourcing services market covered in this report is segmented –

1) By Type: Surrogate Endpoints, Predictive Biomarker, Prognostic Biomarker, Safety Biomarker, Other Biomarker Types

2) By Service Type: Biomarker Validation, Biomarker Testing Services, Biomarker Sample Analysis

3) By Therapeutic Area: Oncology, Neurology, Cardiology, Autoimmune Diseases, Other Therapeutic Areas

4) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic And Research Institutions

Global Biomarker Clinical Phase Outsourcing Services Market Size 2023 to 2028: Graph

Biomarker Clinical Phase Outsourcing Services Market Size 2024 And Growth Rate

The biomarker clinical phase outsourcing services market size has grown exponentially in recent years. It will grow from $7.91 billion in 2023 to $9.71 billion in 2024 at a compound annual growth rate (CAGR) of 22.7%. The growth in the historic period can be attributed to rising government initiatives and funding, increasing diagnostic applications of biomarkers, a rise in R&D funding from the government, rapid advancements in technologies such as genomics, proteomics, and imaging, and the increasing demand for cancer biomarkers.

Biomarker Clinical Phase Outsourcing Services Market Growth Forecast

The biomarker clinical phase outsourcing services market size is expected to see exponential growth in the next few years. It will grow to $22.09 billion in 2028 at a compound annual growth rate (CAGR) of 22.8%. The growth in the forecast period can be attributed to the increasing use of biomarkers in the various phases of clinical trials. The use of biomarkers in clinical trials continues to expand, as does the growing demand for precision medicines, the rising adoption of companion diagnostics, and the and the increasing demand for personalized medicine. Major trends in the forecast period include advanced parameters in the trials, diagnostic-focused clinical phases, rapid advancements in biomarker technology, rising government initiatives and funding, and advancements in technology.

Book your 30 minutes free consultation with our research experts

Biomarker Clinical Phase Outsourcing Services Market Driver: Expanding Clinical Trial Landscape Fuels Growth Of Biomarker Clinical Phase Outsourcing Services Market

The rise in clinical trials is expected to propel the growth of the biomarker clinical phase outsourcing services market going forward. Clinical trials are research studies conducted with human participants to evaluate the safety and effectiveness of new medical treatments, interventions, or diagnostic procedures. The surge in clinical trials is facilitated by advancements in medical research, rising prevalence of chronic diseases, increased funding from both governmental and private sources, and the growing demand for innovative treatments and therapies. Outsourcing providers often have specialized knowledge and experience in biomarker discovery, validation, and analysis. This expertise can enhance the quality and reliability of the biomarker data collected during the trial. For instance, in May 2023, according to the United States National Library of Medicine, registered clinical trials increased from 399,499 in 2022 to 437,533 in all 50 states and across 221 countries. Furthermore, it was reported that 140,492 studies (31%) are registered in the United States only, whereas 241,498 studies (53%) are recorded in non-U.S. locations. Therefore, the rise in clinical trials will drive the growth in the biomarker clinical phase outsourcing services market forward.

Global Biomarker Clinical Phase Outsourcing Services Market Major Players

Major companies operating in the biomarker clinical phase outsourcing services market are Thermo Fisher Scientific Inc., Labcorp Drug Development Inc., ICON plc, Eurofins Scientific SE, WuXi AppTec Co. Ltd., Syneos Health Inc., Intertek Group plc, Charles River Laboratories International Inc., Parexel International Corporation, QIAGEN N.V., Medpace Inc., Bioclinica Inc., Evotec SE, GenScript Biotech Corporation, Precision for Medicine Inc., BioAgilytix Labs LLC, Celerion Inc., Frontage Laboratories Inc., SomaLogic Inc., Selvita S.A., BioIVT LLC, Discovery Life Sciences LLC, Metabolon Inc., Caprion Proteomics Inc., Canopy Biosciences LLC

Global Biomarker Clinical Phase Outsourcing Services Market Trend: Advancements Drive Competition In Biomarker Clinical Phase Outsourcing Services

Major companies in the biomarker clinical phase outsourcing services are focusing on advancements with high-throughput flow cytometry and ELISpot testing to gain a competitive edge in the market. High-throughput flow cytometry and ELISpot testing are utilized for biomarker analysis, offering rapid and precise assessment of immune responses and cellular markers. For instance, in November 2022, Celerion Inc., a US-based biotechnology outsourcing services company, expanded its service offering to include GLP/GCP-compliant molecular and cell biology testing. This strategic move aims to enhance Celerion's capabilities in supporting clients throughout the drug development process, from early clinical research to regulatory submissions. Celerion can provide a more comprehensive range of services by adding GLP/GCP-compliant molecular and cell biology tests, such as pharmacokinetic (PK), pharmacodynamic (PD), and biomarker analysis. This expansion enables Celerion to assist clients in producing high-quality data that meets regulatory requirements, thereby speeding up the development of new medicines.

Biomarker Clinical Phase Outsourcing Services Market Merger And Acquisition: Vitruvian Partners Acquires KCAS Bio To Drive Expansion And Enhance Biotech Service Offerings

In April 2021, Vitruvian Partners LLP, a UK-based private equity firm, acquired KCAS Bio for an undisclosed amount. This investment aims to support KCAS in expanding its operations in Kansas City and enhancing its capabilities to meet the needs of pharmaceutical and biotech clients. This acquisition aligns with Vitruvian Partners' strategy of backing best-in-class companies in vital market sectors with internationalization opportunities. KCAS Bio is a US-based clinical outsourcing company providing bioanalytical and biomarker development testing services.

Regional Insights For The Global Biomarker Clinical Phase Outsourcing Services Market

North America was the largest region in the biomarker clinical phase outsourcing services market in 2023. The regions covered in the biomarker clinical phase outsourcing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biomarker clinical phase outsourcing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The biomarker clinical phase outsourcing services market includes revenues earned by entities by consulting services, diagnostic tests, clinical trial design, and biomarker sample analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The biomarker clinical phase outsourcing services market research report is one of a series of new reports from The Business Research Company that provides biomarker clinical phase outsourcing services market statistics, including biomarker clinical phase outsourcing services industry global market size, regional shares, competitors with an biomarker clinical phase outsourcing services market share, detailed biomarker clinical phase outsourcing services market segments, market trends and opportunities, and any further data you may need to thrive in the biomarker clinical phase outsourcing services industry. This biomarker clinical phase outsourcing services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Biomarker Clinical Phase Outsourcing Services Market Report Forecast and Analysis

Report Attribute	Details
Market Size Value In 2024	$9.71 billion
Revenue Forecast In 2033	$22.09 billion
Growth Rate	CAGR of 22.8% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Type: Surrogate Endpoints, Predictive Biomarker, Prognostic Biomarker, Safety Biomarker, Other Biomarker Types 2) By Service Type: Biomarker Validation, Biomarker Testing Services, Biomarker Sample Analysis 3) By Therapeutic Area: Oncology, Neurology, Cardiology, Autoimmune Diseases, Other Therapeutic Areas 4) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic And Research Institutions
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Thermo Fisher Scientific Inc., Labcorp Drug Development Inc., ICON plc, Eurofins Scientific SE, WuXi AppTec Co. Ltd., Syneos Health Inc., Intertek Group plc, Charles River Laboratories International Inc., Parexel International Corporation, QIAGEN N.V., Medpace Inc., Bioclinica Inc., Evotec SE, GenScript Biotech Corporation, Precision for Medicine Inc., BioAgilytix Labs LLC, Celerion Inc., Frontage Laboratories Inc., SomaLogic Inc., Selvita S.A., BioIVT LLC, Discovery Life Sciences LLC, Metabolon Inc., Caprion Proteomics Inc., Canopy Biosciences LLC
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Biomarker Clinical Phase Outsourcing Services Market Characteristics

3. Biomarker Clinical Phase Outsourcing Services Market Trends And Strategies

4. Biomarker Clinical Phase Outsourcing Services Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Biomarker Clinical Phase Outsourcing Services Market Size and Growth

5.1. Global Biomarker Clinical Phase Outsourcing Services Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Biomarker Clinical Phase Outsourcing Services Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Biomarker Clinical Phase Outsourcing Services Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biomarker Clinical Phase Outsourcing Services Market Segmentation

6.1. Global Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Surrogate Endpoints

Predictive Biomarker

Prognostic Biomarker

Safety Biomarker

Other Biomarker Types

6.2. Global Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Biomarker Validation

Biomarker Testing Services

Biomarker Sample Analysis

6.3. Global Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Oncology

Neurology

Cardiology

Autoimmune Diseases

Other Therapeutic Areas

6.4. Global Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Pharmaceutical Companies

Biotechnology Companies

Academic And Research Institutions

7. Biomarker Clinical Phase Outsourcing Services Market Regional And Country Analysis

7.1. Global Biomarker Clinical Phase Outsourcing Services Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Biomarker Clinical Phase Outsourcing Services Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market

8.1. Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biomarker Clinical Phase Outsourcing Services Market

9.1. China Biomarker Clinical Phase Outsourcing Services Market Overview

9.2. China Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biomarker Clinical Phase Outsourcing Services Market

10.1. India Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biomarker Clinical Phase Outsourcing Services Market

11.1. Japan Biomarker Clinical Phase Outsourcing Services Market Overview

11.2. Japan Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biomarker Clinical Phase Outsourcing Services Market

12.1. Australia Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biomarker Clinical Phase Outsourcing Services Market

13.1. Indonesia Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biomarker Clinical Phase Outsourcing Services Market

14.1. South Korea Biomarker Clinical Phase Outsourcing Services Market Overview

14.2. South Korea Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biomarker Clinical Phase Outsourcing Services Market

15.1. Western Europe Biomarker Clinical Phase Outsourcing Services Market Overview

15.2. Western Europe Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biomarker Clinical Phase Outsourcing Services Market

16.1. UK Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biomarker Clinical Phase Outsourcing Services Market

17.1. Germany Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biomarker Clinical Phase Outsourcing Services Market

18.1. France Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.2. France Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.3. France Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biomarker Clinical Phase Outsourcing Services Market

19.1. Italy Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.2. Italy Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.3. Italy Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biomarker Clinical Phase Outsourcing Services Market

20.1. Spain Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.2. Spain Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.3. Spain Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biomarker Clinical Phase Outsourcing Services Market

21.1. Eastern Europe Biomarker Clinical Phase Outsourcing Services Market Overview

21.2. Eastern Europe Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biomarker Clinical Phase Outsourcing Services Market

22.1. Russia Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biomarker Clinical Phase Outsourcing Services Market

23.1. North America Biomarker Clinical Phase Outsourcing Services Market Overview

23.2. North America Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biomarker Clinical Phase Outsourcing Services Market

24.1. USA Biomarker Clinical Phase Outsourcing Services Market Overview

24.2. USA Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biomarker Clinical Phase Outsourcing Services Market

25.1. Canada Biomarker Clinical Phase Outsourcing Services Market Overview

25.2. Canada Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biomarker Clinical Phase Outsourcing Services Market

26.1. South America Biomarker Clinical Phase Outsourcing Services Market Overview

26.2. South America Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biomarker Clinical Phase Outsourcing Services Market

27.1. Brazil Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biomarker Clinical Phase Outsourcing Services Market

28.1. Middle East Biomarker Clinical Phase Outsourcing Services Market Overview

28.2. Middle East Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biomarker Clinical Phase Outsourcing Services Market

29.1. Africa Biomarker Clinical Phase Outsourcing Services Market Overview

29.2. Africa Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biomarker Clinical Phase Outsourcing Services Market Competitive Landscape And Company Profiles

30.1. Biomarker Clinical Phase Outsourcing Services Market Competitive Landscape

30.2. Biomarker Clinical Phase Outsourcing Services Market Company Profiles

30.2.1. Thermo Fisher Scientific Inc.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Labcorp Drug Development Inc.

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. ICON plc

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Eurofins Scientific SE

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. WuXi AppTec Co. Ltd.

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Biomarker Clinical Phase Outsourcing Services Market Other Major And Innovative Companies

31.1. Syneos Health Inc.

31.2. Intertek Group plc

31.3. Charles River Laboratories International Inc.

31.4. Parexel International Corporation

31.5. QIAGEN N.V.

31.6. Medpace Inc.

31.7. Bioclinica Inc.

31.8. Evotec SE

31.9. GenScript Biotech Corporation

31.10. Precision for Medicine Inc.

31.11. BioAgilytix Labs LLC

31.12. Celerion Inc.

31.13. Frontage Laboratories Inc.

31.14. SomaLogic Inc.

31.15. Selvita S.A.

32. Global Biomarker Clinical Phase Outsourcing Services Market Competitive Benchmarking

33. Global Biomarker Clinical Phase Outsourcing Services Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Biomarker Clinical Phase Outsourcing Services Market

35. Biomarker Clinical Phase Outsourcing Services Market Future Outlook and Potential Analysis

35.1 Biomarker Clinical Phase Outsourcing Services Market In 2028 - Countries Offering Most New Opportunities

35.2 Biomarker Clinical Phase Outsourcing Services Market In 2028 - Segments Offering Most New Opportunities

35.3 Biomarker Clinical Phase Outsourcing Services Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Biomarker Clinical Phase Outsourcing Services Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Global Biomarker Clinical Phase Outsourcing Services Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: Asia-Pacific, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: China, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: India, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Japan, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Australia, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: Indonesia, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: South Korea, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: Western Europe, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: UK, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: Germany, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: France, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Italy, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Spain, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Eastern Europe, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: Russia, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: North America, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: USA, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: Canada, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: South America, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Brazil, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Middle East, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Africa, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 75: Thermo Fisher Scientific Inc. Financial Performance

Table 76: Labcorp Drug Development Inc. Financial Performance

Table 77: ICON plc Financial Performance

Table 78: Eurofins Scientific SE Financial Performance

Table 79: WuXi AppTec Co. Ltd. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Biomarker Clinical Phase Outsourcing Services Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Global Biomarker Clinical Phase Outsourcing Services Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: Asia-Pacific, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: China, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: India, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Japan, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Australia, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: Indonesia, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: South Korea, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: Western Europe, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: UK, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: Germany, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: France, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Italy, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Spain, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Eastern Europe, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: Russia, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: North America, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: USA, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: Canada, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: South America, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Brazil, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Middle East, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Africa, Biomarker Clinical Phase Outsourcing Services Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 75: Thermo Fisher Scientific Inc. Financial Performance

Figure 76: Labcorp Drug Development Inc. Financial Performance

Figure 77: ICON plc Financial Performance

Figure 78: Eurofins Scientific SE Financial Performance

Figure 79: WuXi AppTec Co. Ltd. Financial Performance

Global Healthcare Automation Market 2022 – Market Opportunities And Strategies

Global Central Lab Market 2022 – Market Opportunities And Strategies

What Is The Biohacking Market Overview In 2022?

How Will The Healthcare Claims Management Solutions Market Grow In 2022?

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the video management system market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the single use bioprocessing market research report 2022 with industry size, share, segments and market growth

Bioadhesives Global Market Report 2024 – By Type (Plant-Based, Animal-Based), By Production Methods (Direct Chemical Synthesis, Bacteria And Yeast Fermentation, Natural Organisms Farming ), By Industry (Packaging Industries, Paper And Pulp Industries, Construction Industry, Personal Care, Healthcare, Other Industries) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Biosurfactants Global Market Report 2024 – By Product Type (Glycolipid, Phospholipids, Surfactin, Lichenysin, Polymeric Bio-surfactants, Other Product Types), By Application (Detergents, Personal Care, Food Processing, Agricultural Chemicals, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Probiotics Global Market Report 2024 – By Form (Liquid, Dry), By Ingredient (Bacteria, Yeast), By Application (Food and Beverages, Dietary Supplements, Animal Feed), By End User (Human, Animal), By Distribution Channel (Hypermarkets Or Supermarkets, Pharmacies Or Health Stores, Convenience Stores, Online Retail, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Single-Use Bio Reactors Global Market Report 2024 – By Type (Stirred-Tank SUBs, Wave-Induced SUBs, Bubble-Column SUBs, Other Types), By Molecule Type (Vaccines, Monoclonal Antibodies, Stem Cells, Recombinant Proteins), By Cell Type (Mammalian Cell, Bacteria, Yeast), By Application (Research And Development (R&D), Process Development, Bioproduction), By End User (Pharmaceutical And Biopharmaceutical Companies, Contract Research Organizations (CRO), Academic And Research Institutes, Contract Manufacturing Organizations (CMO)) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Probiotics Dietary Supplements Global Market Report 2024 – By Source (Yeast, Bacteria), By Form (Capsules, Chewables And Gummies, Powders, Tablets And Softgels, Other Forms), By Distribution Channel (Business To Business, Business To Consumer), By Application (Infant Formula, Food Supplement, Specialty Nutrients), By End Use (Infants, Children, Adults, Geriatric) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Bioanalytical Testing Services Global Market Report 2024 – By Test Type (ADME (Absorption, Distribution, Metabolism, And Excretion), Pharmacokinetic, Pharmacodynamic, Bioequivalence, Bioavailability), By Molecule Type (Small Molecules, Large Molecules), By End User (Pharmaceutical And Biopharmaceutical Companies, Contract Development And Manufacturing Organizations, Contract Research Organizations) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Bioprocess Containers Global Market Report 2024 – By Type (2D Bioprocess Containers, 3D Bioprocess Containers, Tank Liners, Other Containers & Accessories), By Application (Process Development, Upstream, Downstream), By End User (Biopharmaceutical Companies, Life Science R&D Companies, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Agricultural Biologics Global Market Report 2024 – By Type (Biopesticides, Biofertilizers, Biostimulants), By Source (Microbials, Macrobials, Biochemicals, Other Sources), By Mode of Application (Foliar Spray, Soil Treatment, Seed Treatment, Post-Harvest), By Application (Cereals And Grains, Oilseed And Pulses, Fruits And Vegetables, Turf And Ornamentals, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the market?

How will the market drivers and restraints affect the market dynamics? What forces will shape the industry going forward?

The market major growth driver - The biomarker clinical phase outsourcing services market size has grown exponentially in recent years. It will grow from $7.91 billion in 2023 to $9.71 billion in 2024 at a compound annual growth rate (CAGR) of 22.7%. The growth in the historic period can be attributed to rising government initiatives and funding, increasing diagnostic applications of biomarkers, a rise in R&D funding from the government, rapid advancements in technologies such as genomics, proteomics, and imaging, and the increasing demand for cancer biomarkers. The biomarker clinical phase outsourcing services market size is expected to see exponential growth in the next few years. It will grow to $22.09 billion in 2028 at a compound annual growth rate (CAGR) of 22.8%. The growth in the forecast period can be attributed to the increasing use of biomarkers in the various phases of clinical trials. The use of biomarkers in clinical trials continues to expand, as does the growing demand for precision medicines, the rising adoption of companion diagnostics, and the and the increasing demand for personalized medicine. Major trends in the forecast period include advanced parameters in the trials, diagnostic-focused clinical phases, rapid advancements in biomarker technology, rising government initiatives and funding, and advancements in technology.. For further insights on the market, request a sample here

What is the forecast market size or the forecast market value of the market?

The biomarker clinical phase outsourcing services market size has grown exponentially in recent years. It will grow from $7.91 billion in 2023 to $9.71 billion in 2024 at a compound annual growth rate (CAGR) of 22.7%. The growth in the historic period can be attributed to rising government initiatives and funding, increasing diagnostic applications of biomarkers, a rise in R&D funding from the government, rapid advancements in technologies such as genomics, proteomics, and imaging, and the increasing demand for cancer biomarkers. The biomarker clinical phase outsourcing services market size is expected to see exponential growth in the next few years. It will grow to $22.09 billion in 2028 at a compound annual growth rate (CAGR) of 22.8%. The growth in the forecast period can be attributed to the increasing use of biomarkers in the various phases of clinical trials. The use of biomarkers in clinical trials continues to expand, as does the growing demand for precision medicines, the rising adoption of companion diagnostics, and the and the increasing demand for personalized medicine. Major trends in the forecast period include advanced parameters in the trials, diagnostic-focused clinical phases, rapid advancements in biomarker technology, rising government initiatives and funding, and advancements in technology. For further insights on the market, request a sample here

How is the market segmented?

The market is segmented
1) By Type: Surrogate Endpoints, Predictive Biomarker, Prognostic Biomarker, Safety Biomarker, Other Biomarker Types
2) By Service Type: Biomarker Validation, Biomarker Testing Services, Biomarker Sample Analysis
3) By Therapeutic Area: Oncology, Neurology, Cardiology, Autoimmune Diseases, Other Therapeutic Areas
4) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic And Research InstitutionsFor further insights on the market, request a sample here

Which region has the largest share of the market? What are the other regions covered in the report?

North America was the largest region in the biomarker clinical phase outsourcing services market in 2023. The regions covered in the biomarker clinical phase outsourcing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on the market, request a sample here.

What are the key trends in the market?

Major trend in the market - Advancements Drive Competition In Biomarker Clinical Phase Outsourcing Services. For further insights on the market, request a sample here.

What are the major opportunities in the market? What are the strategies for the market?

For detailed insights on the major opportunities and strategies in the market, request a sample here.

How does the market relate to the overall economy and other similar markets?

For detailed insights on market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the industry?

For detailed insights on the mergers and acquisitions in the industry, request a sample here.

What are the key dynamics influencing the market growth? SWOT analysis of the market.

For detailed insights on the key dynamics influencing the market growth and SWOT analysis of the industry, request a sample here.